Age

21–64

Sex

FEMALE

Healthy volunteers

Accepted

1. Previous exposure to chemotherapy/anti-hormonal therapy for any other malignancy
2. Previous neoadjuvant therapy for breast cancer
3. Concomitant second primary in-situ or invasive carcinoma or previous history of carcinoma/carcinoma-in-situ
4. Known disease or injury to the central nervous system (including neurodegenerative diseases, epilepsy), severe visual or auditory disorders
5. Motor weakness due to any cause which makes using a touchscreen computer difficult
6. Known background of depression, anxiety disorders or other neurobehavioural conditions
7. Ongoing use of tranquilisers or anti-depressants
8. Previous neuropsychological testing
9. Current or previous history of alcohol or drug dependent

A Prospective Study to Evaluate the Effect of Systemic Adjuvant Therapy on the Cognitive Function of Breast Cancer Patients